Targeted radionuclide therapy for solid tumors: An overview
- 1 October 2006
- journal article
- review article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 66 (2) , S89-S95
- https://doi.org/10.1016/j.ijrobp.2006.03.066
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- High-Dose Radioimmunotherapy Combined with Fixed, Low-Dose Paclitaxel in Metastatic Prostate and Breast Cancer by Using a MUC-1 Monoclonal Antibody, m170, Linked to Indium-111/Yttrium-90 via a Cathepsin Cleavable Linker with Cyclosporine to Prevent Human Anti-mouse AntibodyClinical Cancer Research, 2005
- Radioimmunotherapy of small-volume disease of metastatic colorectal cancerCancer, 2002
- A Phase II Study of [90Y] Yttrium-Capromab Pendetide in the Treatment of Men with Prostate Cancer Recurrence Following Radical ProstatectomyCancer Biotherapy & Radiopharmaceuticals, 1999
- Combined Modality Radioimmunotherapy with Taxol and 90Y-LYM-1 for Raji Lymphoma XenograftsCancer Biotherapy & Radiopharmaceuticals, 1998
- TNP-470 (AGM-1470): Mechanisms of action and early clinical developmentEuropean Journal Of Cancer, 1996
- 186Re-Labeled Antibodies to p185HER2as HER2-Targeted Radioimmunopharmaceutical Agents: Comparison of Physical and Biological Characteristics with125I and131I-Labeled CounterpartsCancer Biotherapy & Radiopharmaceuticals, 1996
- Breast Cancer99mTc Sm3 RadioimmunoscintigraphyActa Oncologica, 1996
- MAb 170H.82Nuclear Medicine Communications, 1992
- Eight-Year Results of a Randomized Clinical Trial Comparing Total Mastectomy and Lumpectomy with or without Irradiation in the Treatment of Breast CancerNew England Journal of Medicine, 1989
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971